Phase 2a study of intravenous CT-P27 post-exposure to Influenza A H3N2

• Research type

  Research Study

• Full title

  A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

• IRAS ID

  140943

• Contact name

  Ganesh Balaratnam

• Contact email

  g.balaratnam@retroscreen.com

• Sponsor organisation

  Celltrion, Inc.

• Eudract number

  2013-004544-32

• REC name

  London - City & East Research Ethics Committee

• REC reference

  14/LO/0051

• Date of REC Opinion

  10 Feb 2014

• REC opinion

  Further Information Favourable Opinion